3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
43
Terminated
9
Withdrawn
1
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Classical hematology
1
Conditions
Anemia
1
Interventions
Peripheral Blood Stem Cell Transplantation
4
fludarabine phosphate
2
Whole-Body Irradiation
2
Methotrexate
2
Cyclosporine
2
Cyclophosphamide
2
Busulfan
2
siltuximab
1
pegylated granulocyte colony-stimulating factor
1
magrolimab
1
hetrombopag
1
fludarabine
1
ferric gluconate
1
decitabine and cedazuridine drug combination
1
ceftolozane, tazobactam drug combination
1
avatrombopag
1
Transplantation
1
Tacrolimus
1
Radiotherapy
1
Pluvicto
1
Pentostatin
1
Mycophenolic Acid
1
Micafungin
1
Meropenem
1
Iron-Dextran Complex
1
Iron
1
In Situ Hybridization, Fluorescence
1
Immunoenzyme Techniques
1
Holistic Health
1
Genotype
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Epoetin Alfa
×
Classical hematology
×
Clear all
NCT00481624
2018-03-05
Procrit
University of Louisville
Phase 2
Withdrawn